Nanoclast iconNanoclast

Faster and Cheaper Process for Graphene in Li-ion Batteries

Over the last couple of years, research to improve lithium-ion (Li-ion) batteries have been turning to graphene, particularly after researchers at Northwestern University successfully sandwiched a layer of silicon between graphene sheets in the anodes of Li-ion batteries.

But most of the Li-ion battery work being done with graphene to date has depended on high-vacuum environments to create the layered material. Now Gurpreet Singh, a Kansas State University assistant professor of mechanical and nuclear engineering, is leading a team that's looking at faster and cheaper ways of synthesizing the material.

"We are exploring new methods for quick and cost-effective synthesis of two-dimensional materials for rechargeable battery applications," Singh said in a university press release.

The two-dimensional materials to which Singh refers includes not only graphene but also tungsten disulfide nanosheets. In his work with graphene, which was published in the journal Applied Materials & Interfaces (“Synthesis of Graphene Films by Rapid Heating and Quenching at Ambient Pressures and Their Electrochemical Characterization”),Singh’s team was able to create the graphene outside of a vacuum.

Read More

Graphene Could Help Prevent Another Lance Armstrong

After a professional cycling career in which he claimed repeatedly to have never given a positive drug test, Lance Armstrong has reportedly confessed to using performance-enhancing drugs in achieving his Tour de France victories.

While his confession will likely raise a lot of questions, surely one has to be how could the drug tests have failed in detecting the illicit drugs? Great advances have been made in drug testing since Lance Armstrong won his first Tour de France in 1999. At that time, there was no test for EPO—the drug of choice of endurance athletes looking for an edge—but a test was developed in 2000. Nonetheless, Armstrong and many others who have recently confessed got away with it between 2000 and now despite the new tests.

Now drug testing may have a new ally in combating cheating in professional cycling and all professional sports. Researchers at the University of Manchester in the UK in cooperation with colleagues at Aix-Marseille University in France are reporting on an optical system—enabled by esoteric stuff such as metamaterials, plasmonics, and singular optics along with the wonder material graphene—to detect a single molecule of a drug in a few minutes.

The research, which is published in the journal Nature Materials (“Singular phase nano-optics in plasmonic metamaterials for label-free single-molecule detection”), is essentially a proof of concept for new sensing devices that exploit the field of singular optics, which operates on the phenomena of abrupt phase changes to light.

Read More

Nanocoatings for Waterproofing Mobile Devices Continue to Make a Splash at CES

Last year’s edition of the Consumer Electronics Show saw the introduction of the waterproof mobile phone. This year’s iteration of CES marks waterproofed gadgets' sophomore year return, and for at least one company, the announcement of a new chemistry for the nanocoating that makes phones more waterproof than they were last year.

In a blog post last year, IEEE Spectrum editor Tekla Perry suggested that a patent battle might be brewing between HzO and Liquipel, makers of the coatings that keep water out. But that intellectual property fight doesn’t seem to have materialized. The patent concerns stemmed from both Liquipel’s and HzO’s relationship with a company called Zagg, which sells and markets protective casings for mobile devices. HzO approached Zagg to help it market its nanocoating product. Later, executives from Zagg left the company to form Liquipel, which raised some suspicions.

From my cynical perspective, I suspected that Liquipel’s recently announced new chemistry was motivated by these patent infringement concerns. But an industry insider informed me that Liquipel’s new chemistry was more likely to have been driven by improving product features than any concerns over patents.

Both Liquipel (Santa Ana, Ca.) and HzO (Draper, Utah) may have been driven to step their respective games up by two other rivals in the market: Neverwet, based in Leola, Pa., and P2i Ltd. of Abingdon, UK. (It should be noted that P2i also has a U.S. subsidiary in Savannah, Ga., P2i Inc.) Each of these four players is looking to grab market share by demonstrating to gadget makers that its nanocoating is better and that its waterproofing process costs less.

Read More

Nanoparticle Enables World Record for Energy Storage in Batteries

With just one week under our belts in this New Year, we already have some world-record news in relation to lithium-ion (Li-ion) batteries and nanoparticles. Researchers at Stanford University and the SLAC National Accelerator Laboratory have developed a Li-ion battery in which its sulfur cathode was capable of storing five times more energy than is possible with today’s commercially available batteries.

The research—not surprisingly—was led by Stanford’s Yi Cui. What may be somewhat surprising is that Cui has focused his attention in this research on the cathode rather than the anode of the battery. Much of Cui’s most recent work has been on improving the anodes of Li-ion batteries through the use of nanostructured silicon. In this latest research, he has not only shifted his attention to the cathode, but also developed an entirely new material to do it.

The new material, which is described in the Jan. 8 edition of Nature Communications (“Sulphur–TiO2 yolk–shell nanoarchitecture with internal void space for long-cycle lithium–sulphur batteries”),  is a nanoparticle that is made up of an inner core of sulfur surrounded by an outer layer of porous titanium-oxide. The nanoparticles architecture resembles that of the yolk and shell of an egg.

This nanoparticle’s new architecture has broken down an obstacle to using sulfur in the cathode of Li-ion batteries that has persisted for around 20 years.

While it has been known that sulfur could store more lithium ions than other cathode materials, the combination of sulfur atoms with lithium ions resulted in a compound—though necessary for the cathode to operate—that kept dissolving and limited the storage capacity of the battery. Also, when the lithium ions went into the cathode, it would expand the size of the cathode by 80 percent. Attempts to employ protective coatings to correct the first problem of the compound dissolving just resulted in them cracking as soon the lithium ions expanded the cathode.

Read More

Graphene Takes Aim at Treating Alzheimer’s and Cancer

When graphene was first introduced, it seemed everyone wanted to apply it to electronics, especially after carbon nanotubes were turning into such a disappointment in the field.  But graphene has a huge strike against it in electronics: it lacks a band gap. So everyone, including major electronics players like IBM and Samsung, looked for ways to give graphene a band gap.

While researchers were hard at work wrestling graphene into a role it didn’t seem to want to play, others were looking at what it might like to do. This led to work that looked at using graphene for applications ranging from rustproofing to photovoltaics.

Now the biomedical field is increasingly looking at graphene as a material for advancing therapeutics and diagnostics where its capabilities might be ideally suited. An article in the journal Advanced Materials ("New Horizons for Diagnostics and Therapeutic Applications of Graphene and Graphene Oxide") outlines some of the ways that graphene and its oxide are promising improved diagnostics and therapeutics for maladies ranging from Alzheimer’s to cancer.

Of course, some of the applications for graphene in the biomedical field are within areas that are at least tangential to those already mentioned, like electronic devices and transparent conductors. But graphene is also being looked at for drug and gene delivery applicationsphoto-therapy of cancer  and biosensors. In particular, researchers have been experimenting with combining graphene with near-Infrared (NIR) phototherapy and imaging.  There has been some progress in using graphene-enabled NIR photothermal therapy for cancer and Alzheimer's disease (AD).

While both pure graphene and graphene oxide have exhibited some toxicity to cell and animals, it has been found that coating the graphene with a biocompatible polymer results in no detectable toxicity in both cellular and animal testing.

Graphene’s application to this field is still in its infancy, however, early testing has shown promise that it could play an important role in future disease diagnostics and treatment.

Image:  Luis E. F. Foa Torres

Graphene Still Trying to Replace ITO in Organic Solar Cells

Almost two years ago, researchers at MIT were heralding graphene as a possible replacement for the expensive indium-tin-oxide used in electrodes for organic solar cells. They showed a way in which the entire solar cell could be flexible—including its electrodes—and transparent.

Not long after that, research at Rice University picked up on the use of graphene for replacing ITO, but aimed their work towards creating a thin film for touch-screen displays.

Now researchers at MIT are reporting on work that, like the Rice team, combines flexible sheets of graphene with a grid of metallic nanowires. In so doing, they turned their attention back to photovoltaics. The research (“Graphene Cathode-Based ZnO Nanowire Hybrid Solar Cells”) was published in the journal Nano Letters.

While this latest research is not the first time graphene was used a replacement for ITO—even at MIT—it does have the distinction of being a graphene-nanowire solar cell with a respectable energy conversion efficiency of 4.2 percent. While this may not sound like a world-beating number, it stands up well to that of ITO-based devices with similar architectures.

“We’ve demonstrated that devices based on graphene have a comparable efficiency to ITO,” says Silvija Gradečak, one of the MIT researchers involved in the project, in a press release. “We’re the first to demonstrate graphene-nanowire solar cells without sacrificing device performance.”

Read More

Fundamental Photoconductivity Mechanisms of Graphene Revealed

A team from the IBM Nanoscale Science and Technology group has revealed some of the fundamental mechanisms of photoconductivity in graphene. In particular, the researchers demonstrated that the photoconductivity of graphene can be either positive or negative depending on its gate bias.

The research team includes Marcus Freitag, Tony Low, Fengnian Xia and Phaedon Avouris (who we interviewed on this blog for his work in creating a band gap in graphene). The group works out of IBM's T. J. Watson Research Lab, in Yorktown Heights, N.Y. and published their work (“Photoconductivity of graphene”) in the online version of Nature Photonics.

The impetus for their “classic photoconductivity experiment” was the appealing optoelectronic properties of graphene. It at once possesses high carrier mobility, zero bandgap, and electron-hole symmetry.

Read More

Nanoparticle Coated Lens Converts Light into Sound for Precise Non-invasive Surgery

Remember how Leonard McCoy performed surgery in Star Trek? He would wave a device over the patient. The outer layers of the skin didn't need not be cut, even when operating on internal organs, and the precision of 23rd century instrument reached down to the level of individual cells.

Well, we already have a bit of that in the 21st. Research at the University of Michigan, led by Jay Gou, has developed a device that employs a carbon-nanotube-coated lens capable of converting light into tightly focused sound waves. The new ultrasound therapeutic tool that reaches new levels of precision—its high-amplitude sound waves are able to target an object with dimensions of 75 by 400 micrometers.

In the image to the right, you can see a150-µm hole that the researchers drilled into a confetti-sized artificial kidney stone.

"A major drawback of current strongly focused ultrasound technology is a bulky focal spot, which is on the order of several millimeters," says Hyoung Won Baac, who worked on the project as a doctoral student and is now a research fellow at Harvard Medical School, in a press release. "A few centimeters is typical. Therefore, it can be difficult to treat tissue objects in a high-precision manner, for targeting delicate vasculature, thin tissue layer and cellular texture. We can enhance the focal accuracy 100-fold."

Read More

DNA Nanotechnology Takes Two Big Steps Forward in Manufacturing

A fundamental, unproven assumption in the field of DNA nanotechnology was that the nanoscale objects produced through DNA self-assembly achieved atomically precise positional accuracy.

Researchers at Technische Universitaet Muenchen (TUM), led by Hendrik Dietz, have challenged that assumption head on and built a 3-D object using DNA self assembly techniques and found that indeed the object met its design specifications down to the sub-nanometer scale.

For years now, research has shown that DNA could be programmed to take the shape of pre-determined objects. If a five-pointed star was desired, it was possible to program the DNA so that it took a shape that resembled very closely the original design. But no one really knew if the final objects met the original designs at the atomic scale.

To prove this assumption, the TUM researchers designed a test object that was suitable for low-temperature electron microscopy. This object allowed for an electron density map to be generated of the object in which the resolution of the map was sufficient for a pseudo-atomic model that could be flexibly fitted to the entire object. The object, which was comprised of 460 000 atoms, incorporated a variety of designs that should make it useful in further study in the field.

A video describing the object and its model can be seen below along with further information about the research, which was published in the journal Proceedings of the National Academy of Sciences:

Finally having proof of the atomic precision of the DNA manufactured objects is a huge confirmation for the hopes of bottom-up manufacturing.

Read More

Sale of A123 Systems to Chinese-Owned Company Points to Futility of Nationalistic Technology Investments

The continuing saga of A123 Systems Inc. has culminated this past week in most of its assets being sold for US $256.6 million to the Chinese-owned Wanxiang America Corporation, an auto parts conglomerate.

The sale of A123 to Wanxiang had been in the works since this past August. But because of strong opposition from Washington politicians the final sale was delayed.  The main objection to the sale centered on the fact that the US government had floated A123 a “grant” for $250 million as recently as 2009 to expand the company’s production capacity.

Why the US government would give a grant to expand the company’s production capacity when the market problem it faced was that its main customer wasn’t selling any of its own products is probably a worthy discussion. However, combating crony capitalism with more crony capitalism, which some U.S. Senators seemed engaged in with their fight to block the sale, hardly seems to be a solution.

There were concerted efforts by U.S.-based Johnson Controls Inc. to purchase the bulk of A123’s assets. But the prospect of paying Wanxiang back the $75 million the Chinese company had loaned A123 before A123's bankruptcy likely poured cold water on any other plausible deal.

For anyone seeking—from a U.S. nationalistic perspective—some sort of positive takeaway from the deal perhaps comfort can be taken in the news that Navitas Systems, an Illinois battery company, will get all of A123’s defense contracts.

I am sure that this sale is a bitter pill to swallow, especially for those who believe that national nanotechnology investments will translate into new jobs and economic growth.  We have already seen how, after years of government investment in nanotechnology research and commercialization, the benefiting companies can be easily picked up for a song. Not just by shrewd investors, but by other governments.

The last U.S.-based nanotechnology-based Li-ion battery company to go bankrupt (Ener1) ended up being purchased by a Russian interest. Even the former CEO of Ener1 served as an advisor to Wanxiang in its purchase of the A123 assets.

Governments around the world are going to have to come to terms with the notion that investments in technology have a slim chance of producing jobs and economic growth within the region that happens to make those investments. It may in fact be the only the chance, but in the current innovation framework those chances remain slim. A123 beat the odds; it managed to turn a university research project into a commercial product. There just wasn’t any market for the product.

What governments should be doing is reexamining the entire innovation infrastructure. Apparently, they have not done this to date because there has been no pressure to do so. Sure, technology that has been languishing for years in research labs never seems to get to market, but nobody misses what wasn’t there in the first place. But once it leaves the lab for the marketplace there's something to miss: the millions—even billions—being spent without much to show for it.



IEEE Spectrum’s nanotechnology blog, featuring news and analysis about the development, applications, and future of science and technology at the nanoscale.

Dexter Johnson
Madrid, Spain
Rachel Courtland
Associate Editor, IEEE Spectrum
New York, NY
Load More